About Centivax
Centivax is a company based in San Francisco (United States) founded in 2019.. Centivax has raised $92 million across 5 funding rounds from investors including NIH, US Navy and Gates Foundation. Centivax offers products and services including Broad-Spectrum Vaccine. Centivax operates in a competitive market with competitors including Medeloop, Pure Biologics, Hyku Biosciences, Sirion Biotech and Taizhou Baiying Biotechnology, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$92 M (USD)
in 5 rounds
-
Latest Funding Round
$37 M (USD), Series A
Mar 30, 2026
-
Investors
NIH
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Centivax
Centivax offers a comprehensive portfolio of products and services, including Broad-Spectrum Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pre-clinical vaccine for preventing all influenza strains in animals.
Unlock access to complete
Unlock access to complete
Funding Insights of Centivax
Centivax has successfully raised a total of $92M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $37 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $37.0M
-
First Round
First Round
(14 Aug 2019)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2026 | Amount | Series A - Centivax | Valuation | Structure Fund | |
| Jul, 2025 | Amount | Grant - Centivax | Valuation |
investors |
|
| Jul, 2025 | Amount | Series A - Centivax | Valuation | Future Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Centivax
Centivax has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, US Navy and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering funding and tools for startups in technology and investment sectors.
|
Founded Year | Domain | Location | |
|
Future Ventures is focused on early-stage venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Centivax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Centivax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Centivax Comparisons
Competitors of Centivax
Centivax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medeloop, Pure Biologics, Hyku Biosciences, Sirion Biotech and Taizhou Baiying Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery services are offered by Medeloop as a CRO.
|
|
| domain | founded_year | HQ Location |
Specialized CRO with expertise in recombinant protein production and purification
|
|
| domain | founded_year | HQ Location |
Covalent medicines platform is advanced for drug discovery targeting proteins.
|
|
| domain | founded_year | HQ Location |
Customized AAV-based viral vectors for gene therapy are supplied.
|
|
| domain | founded_year | HQ Location |
Antibody-drug research and development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Centivax
Frequently Asked Questions about Centivax
When was Centivax founded?
Centivax was founded in 2019.
Where is Centivax located?
Centivax is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Centivax a funded company?
Centivax is a funded company, having raised a total of $92M across 5 funding rounds to date. The company's 1st funding round was a Series A of $45M, raised on Aug 14, 2019.
What does Centivax do?
Centivax was established in 2019 and is based in San Francisco, United States. Drug discovery services are offered by the company within the biotechnology sector, focusing on early-stage research and development for therapeutics. Operations include target identification, compound screening, and preclinical validation, conducted by a team leveraging the regions scientific resources. The domain centivax.com is utilized for online presence and client engagement.
Who are the top competitors of Centivax?
Centivax's top competitors include Medeloop, Pure Biologics and Sirion Biotech.
What products or services does Centivax offer?
Centivax offers Broad-Spectrum Vaccine.
Who are Centivax's investors?
Centivax has 15 investors. Key investors include NIH, US Navy, Gates Foundation, HHS, and CEPI.